ACLEXA

This brand name is authorized in Croatia, Estonia, Lithuania, Malta, Poland, Romania.

Active ingredients

The drug ACLEXA contains one active pharmaceutical ingredient (API):

1	Celecoxib UNII JCX84Q7J1L - CELECOXIB
	Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.
	Read more about Celecoxib

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AH01	Celecoxib	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1596696, 1596708, 1596719, 1596720, 1596731, 1596742, 1596753, 1596764, 1596775, 1596786, 1596797, 1596809, 1596810, 1596821, 1596832, 1596843, 1815421, 1815432, 1815443, 1815454, 1815465, 1815476, 1815487, 1815498, 1861343, 1861354, 1861365, 1861376, 1861387, 1861411
HR	Agencija za lijekove i medicinske proizvode	HR-H-575399681, HR-H-588044913
LT	Valstybinė vaistų kontrolės tarnyba	1068247, 1068248, 1072200, 1072201, 1072202, 1072203, 1072204, 1072205, 1072206, 1072207, 1072208, 1072209, 1072210, 1072211, 1072212, 1072213
MT	Medicines Authority	MA982/00901, MA982/00902, PI1438/06701A, PI1438/06702A, PI908/23001A, PI908/23002A
PL	Rejestru Produktów Leczniczych	100316800, 100316817
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60519001, W60519002, W60519003, W60519004, W60519005, W60519006, W60519007, W60519008, W60520001, W60520002, W60520003, W60520004, W60520005, W60520006, W60520007, W60520008